LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 3 | B08 | 72 | hr | 1097 | 1980 | 3769 | 0.5253 | 0.3303 |
BT-20 | HG-5-88-01 | 3.33 | uM | LJP6 | 1 | A20 | 72 | hr | 1097 | 3153 | 3769 | 0.8364 | 0.7693 |
BT-20 | HG-5-88-01 | 3.33 | uM | LJP6 | 2 | A20 | 72 | hr | 1097 | 3417 | 3769 | 0.9065 | 0.8681 |
BT-20 | HG-5-88-01 | 3.33 | uM | LJP6 | 3 | A20 | 72 | hr | 1097 | 3391 | 3769 | 0.8996 | 0.8584 |
BT-20 | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 1097 | 3460 | 3769 | 0.9179 | 0.8842 |
BT-20 | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 1097 | 3310 | 3769 | 0.8781 | 0.8280 |
BT-20 | Imatinib | 3.33 | uM | LJP6 | 3 | N14 | 72 | hr | 1097 | 3731 | 3769 | 0.9898 | 0.9856 |
BT-20 | JNK-9L | 3.33 | uM | LJP6 | 1 | K20 | 72 | hr | 1097 | 818 | 3769 | 0.2170 | -0.1045 |
BT-20 | JNK-9L | 3.33 | uM | LJP6 | 2 | K20 | 72 | hr | 1097 | 980 | 3769 | 0.2600 | -0.0439 |
BT-20 | JNK-9L | 3.33 | uM | LJP6 | 3 | K20 | 72 | hr | 1097 | 865 | 3769 | 0.2295 | -0.0869 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 1 | B20 | 72 | hr | 1097 | 1736 | 3769 | 0.4605 | 0.2390 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 2 | B20 | 72 | hr | 1097 | 1958 | 3769 | 0.5194 | 0.3221 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 1097 | 1743 | 3769 | 0.4624 | 0.2417 |
BT-20 | Lapatinib | 3.33 | uM | LJP6 | 1 | M20 | 72 | hr | 1097 | 3293 | 3769 | 0.8736 | 0.8217 |
BT-20 | Lapatinib | 3.33 | uM | LJP6 | 2 | M20 | 72 | hr | 1097 | 3396 | 3769 | 0.9009 | 0.8602 |
BT-20 | Lapatinib | 3.33 | uM | LJP6 | 3 | M20 | 72 | hr | 1097 | 3494 | 3769 | 0.9269 | 0.8969 |
BT-20 | LDN-193189 | 3.33 | uM | LJP5 | 1 | G02 | 72 | hr | 1097 | 229 | 3769 | 0.0608 | -0.3249 |
BT-20 | LDN-193189 | 3.33 | uM | LJP5 | 2 | G02 | 72 | hr | 1097 | 350 | 3769 | 0.0929 | -0.2796 |
BT-20 | LDN-193189 | 3.33 | uM | LJP5 | 3 | G02 | 72 | hr | 1097 | 492 | 3769 | 0.1305 | -0.2265 |
BT-20 | Linifanib | 3.33 | uM | LJP6 | 1 | J08 | 72 | hr | 1097 | 3667 | 3769 | 0.9728 | 0.9616 |
BT-20 | Linifanib | 3.33 | uM | LJP6 | 2 | J08 | 72 | hr | 1097 | 3677 | 3769 | 0.9755 | 0.9654 |
BT-20 | Linifanib | 3.33 | uM | LJP6 | 3 | J08 | 72 | hr | 1097 | 3874 | 3769 | 1.0277 | 1.0391 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 1097 | 3694 | 3769 | 0.9800 | 0.9717 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 2 | O20 | 72 | hr | 1097 | 3643 | 3769 | 0.9664 | 0.9527 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 3 | O20 | 72 | hr | 1097 | 3228 | 3769 | 0.8563 | 0.7974 |